Worldwide Epithelial Cell Culture Media Industry to 2028 - Prospering Biopharmaceuticals Industries in Different Countries Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Epithelial Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type and End User" report has been added to ResearchAndMarkets.com's offering.

The epithelial cell culture media market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.36% during 2020-2028.

The growth of the market is mainly attributed to the key driving factors such as the increasing applications of epithelial cells and surge in funding for epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines hinders the market growth.

Epithelial cells isolated from tracheal, bronchial, distal respiratory tract, mammary, prostate, vaginal, cervical, and renal tissues, among others, mimic the physiological state of cells in vivo. These cells are valuable in biology research to understand the function of living systems. Cervical epithelial cells provide an in vitro model for studying physiological processes associated with diseases such as cervical cancer, cervical polyps, and human papilloma virus (HPV) disease. The 3D model epithelial cells are used in disease modeling, molecule absorption, toxicity studies, and drug discovery, among others. For several decades, cell-based assays have been widely in use in drug discovery. 2D models provide valuable information on early biological responses and are suitable for high-throughput drug screening, but they offer poor predictive capabilities. Further, epithelial cell lines are used in studies of drug transport processes. Drug transport studies in epithelial cells can be performed easily under controlled conditions, and they generate of important information.

With the increasing applications of epithelial cells, the demand for media required to culture these cell lines is also on rise, which is boosting the epithelial cell culture media market growth.

Based on product type, the epithelial cell culture media market is segmented into human mammary epithelial cells, bronchia/trachea epithelial cells, and renal epithelial cells. By end user, the market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical companies segment held the largest share of the market in 2020. Biopharmaceuticals has been the fastest-growing area of the pharmaceutical business in recent years, with more than 200 approved treatments and hundreds more in development, while the pharmaceutical industry, as a whole, has struggled with single-digit growth, narrower pipelines, and pressure from an ever-aggressive generics business. This is likely to favor the market growth during the forecast period.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the epithelial cell culture media market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global epithelial cell culture media market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

• Increasing Applications of Epithelial Cells
• Surge in Funding for Epithelial Cell Research

Restraints

• Risk of Contamination, Misidentification, and Random Alternations in Cell Lines

Opportunities

• Prospering Biopharmaceuticals Industries in Different Countries

Future Trends

• Adoption of Regenerative Medicines

Companies Mentioned

• PromoCell GmbH
• Merck KGaA
• ATCC
• AXOL Bioscience Ltd.
• Thermo Fisher Scientific Inc.
• Bio-Techne Corporation
• Celprogen Inc.
• Lonza Group AG
• HiMedia Laboratories
• Cell Biologics Inc

For more information about this report visit https://www.researchandmarkets.com/r/wgplbr

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900